Article Text

Download PDFPDF
National Institute for Health and Care Excellence guidelines on myocardial revascularisation
  1. Richard J Jabbour1,2,
  2. Nick Curzen1,2
  1. 1 Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
  2. 2 Faculty of Medicine, University of Southampton, Southampton, UK
  1. Correspondence to Professor Nick Curzen, Wessex Cardiac Unit, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK; nick.curzen{at}


Cardiologists in the UK predominantly use the National Institute for Health and Care Excellence (NICE) and European Society of Cardiology guidelines to help guide decision-making. This article will appraise the current recommendations from NICE regarding myocardial revascularisation and compare them with other major international guidelines. While there are many similarities, subtle differences exist. These differences arise in part due to the evidence base at time of publication, as well as from the different healthcare systems that they are designed for, and from the cost-effectiveness models that dominate the methodology used by NICE. The clinical implications of the differences between the international guidelines will be analysed.

  • Myocardial Infarction
  • Angina Pectoris
  • Percutaneous Coronary Intervention

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter @DrR_Jabbour, @ncurzen

  • Contributors RJ and NC contributed equally to this manuscript. NC provided expert appraisal and additional viewpoints.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests NC—unrestricted research grants from Boston Scientific, Heartflow and Beckman Coulter; speaker fees/consultancy from Abbot Vascular, Heartflow and Boston Scientific; and travel sponsorship from Edwards, Biosensors, Abbot, Lilly/D-S, St Jude Medical and Medtronic. RJ—none declared.

  • Provenance and peer review Commissioned; externally peer reviewed.